ED
LLTC

Exane Derivatives’s Linear Technology Corp LLTC Stock Holding History

Exane Derivatives’s Portfolio LLTC Stock Details LLTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-331
Closed -$20.6K – 712
2016
Q4 		$20.6K Hold
331
– – ﹤0.01% 363
2016
Q3 		$19.6K Hold
331
– – ﹤0.01% 365
2016
Q2 		$15.4K Buy
+331
New +$15.1K ﹤0.01% 349

Other funds holding LLTC

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $762M AUM 23.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Exane Derivatives's LLTC Position: Q1 2017 in Review

Exane Derivatives sold out of Linear Technology Corp (LLTC) in Q1 2017, closing a stake of 331 shares — an estimated $20.6K sold.

Exane Derivatives first reported a position in LLTC in Q2 2016 and held it in 3 quarters. The position peaked at $20.6K in Q4 2016. 5 funds tracked by Wall St. Rank hold LLTC as of Q1 2017.

  • Exane Derivatives reported no remaining Linear Technology Corp position as of Q1 2017 after selling out during the quarter.
  • Exane Derivatives sold 331 Linear Technology Corp shares in Q1 2017, an estimated $20.6K.
  • Exane Derivatives first reported a position in Linear Technology Corp in Q2 2016 and held it in 3 quarters.
  • Exane Derivatives's Linear Technology Corp position peaked at $20.6K in Q4 2016.
  • 5 funds tracked by Wall St. Rank held Linear Technology Corp as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.